All News #Library
Biotech
Inotrem Reveals Nangibotide Clinical Strategy for Septic Shock
23 Jul 2025 //
GLOBENEWSWIRE
Inotrem Reaches Agreement with the FDA for a Phase 3 Trial for Nangibotide
08 Jan 2024 //
BUSINESSWIRE
Inotrem Announces Publication of Two Key Articles on Nangibotide PII Programs
01 Jun 2023 //
BUSINESSWIRE

Market Place
Sourcing Support